San Rocco Therapeutics Announces Major Advances Toward Clinical Development of MiNiRoLu™ Gene Therapy at ESGCT 2026
New manufacturing and therapeutic protein expression data support advancement of an investigational gene therapy for sickle cell disease and beta-thalassemia